Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025